BIOPORTO DIAGNOSTICS A/S: Financial statements 2016
CVR: 18645882
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
BIOPORTO DIAGNOSTICS A/S (CVR 18645882) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 20,720,135 and a net result of DKK -28,940,140 compared with DKK -17,453,206 the year before. That is an increase of 1.7% compared with the year before. The profit margin was -139.7%. Equity in the 2016 report amounted to DKK -216,119,936. The company had 19 employees in the financial year.
- Revenue
- DKK 20,720,135
- Gross Profit
- DKK 5,977,263
- Profit/Loss
- DKK -28,940,140
- Equity
- DKK -216,119,936
- Total Assets
- DKK 13,719,109
- Employees
- 19
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 20.7 mio. | 6 mio. | -28.9 mio. | -216.1 mio. | 19 |
| 2015 | 20.4 mio. | 5.5 mio. | -17.5 mio. | -187.9 mio. | 17 |
| 2014 | 18.7 mio. | 4.6 mio. | -22.8 mio. | -170.4 mio. | - |
| 2013 | 16.6 mio. | -1.2 mio. | -20.6 mio. | -146.4 mio. | - |
| 2012 | 17.9 mio. | 11.1 mio. | -15.1 mio. | -125.8 mio. | 20 |
Official annual report
Find more companies like BIOPORTO DIAGNOSTICS A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
BIOPORTO DIAGNOSTICS A/S has published its annual report for 2015. Revenue came to DKK 20,383,088, and the net result was DKK -17,453,206.
About BIOPORTO DIAGNOSTICS A/S
BIOPORTO DIAGNOSTICS A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1995. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ANTIBODYSHOP A/S and IMMUNOLEX ApS. The management consists of Carsten Buhl. The board consists of Gry Louise Husby Larsen (chair), Carsten Buhl and Klaus Juhl Wulff. The company is owned by BIOPORTO A/S. The company has 29 employees (2026). In 2025, the company reported revenue of DKK 40,286,970 and a net result of DKK -81,398,096 compared with DKK -110,908,377 the year before. Equity in the 2025 report amounted to DKK -837,580,713.